Nvidia, Meta, Revolution Medicines, Abercrombie, Intuit, Salesforce, Moderna, and More Stocks That Explain Today’s Market

Salesforce Stock Surges on Solid Earnings, Expanded Anthropic Partnership

OpenAI Explains How Hugging Face ‘Incident’ Happened

Why Is Intuit Stock Tumbling After a Strong Quarter?

Tiny Nuclear Reactors Are Coming to Army Bases. AI Data Centers Could Be Next.

HP Keeps Getting Squeezed by ‘RAMageddon’

The New York Rangers Are Among the Most Valuable NHL Teams—but Aren’t Profitable

Gap Earnings Have a Low Bar to Clear After Last Quarter’s Mess

CrowdStrike, Okta Stocks Jump. AI Adoption Is Boosting Security Demand.

Best Buy Earnings Loom Following the Stock’s Big Run

Dollar Tree Stock Has Gained, But Earnings Will Test the Retailer’s Strategy

Bond Yields Are Rising. What Investing Pros Say to Do Now.

Revolution Medicines Wins FDA Approval for Pancreatic Cancer Pill. What It Means for the Stock.

Dollar General Stock Has Struggled This Year. Can Earnings Turn Things Around?

SpaceX Spending Spree Knows No Limits. That’s OK With Wall Street.

Vanguard to Buy Wealth Platform Altruist. It’s Going After a Business Schwab and Fidelity Dominate.

Small-Caps, Bitcoin, and a Cathie Wood Buffer: 3 New ETFs

Citizens Private Wealth Recruits $1 Billion Financial Advisory Duo From Northern Trust

Apple Sets Launch Event for Sept. 9. Is the Foldable iPhone Coming?

Private-Equity Firm Vistria Is Buying Stake in $14 Billion Wealth Manager Curi Capital

Meta’s $18 Billion Settlement Is a Win—But Big Questions Remain

How ‘Cash Returns’ Are Replacing AI Momentum

How China’s 2023 Micron Ban Became a Blessing in Disguise for the Stock

Tariffs Hurt Williams-Sonoma More Than the Housing Market

Waymo Heads to Germany as the Global Robo-Taxi War with Tesla Heats Up